Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

Ongoing surveillance and tailored interventions are crucial for at-risk PWH amid evolving SARS-CoV-2 variants. Tenofovir did not prevent SARS-CoV-2 infection or COVID-19.

Authors

Institutions

Publication Details

Journal
International Journal of Infectious Diseases
Published
2024-10-18
DOI
https://doi.org/10.1016/j.ijid.2024.107266
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

Lorena de la Mora, Ana González-Cordón, María Ángeles Marcos, Natalia Egri et al.
International Journal of Infectious Diseases
COVID-19 Clinical Research Studies
article

Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

Lorena de la Mora, Ana González-Cordón, María Ángeles Marcos, Natalia Egri, Maria Martínez‐Rebollar, Juan Ambrosioni, Iván Chivite, Mar Mosquera, Daniel K. Nomah, Cristina Rovira, Josep Mallolas, Alexy Inciarte, José Alcamı́, Berta Torres, Xabier Filella, Estebán Martínez, Yesika Díaz, Naira Rico, Montserrat Laguno, Andreu Bruguera, José Luís Blanco, José M Miró, Elisa de Lazzari, Carmen Hurtado, Raquel Díaz Ruiz, Sonsoles Sánchez-Palomino
article en

Abstract

Ongoing surveillance and tailored interventions are crucial for at-risk PWH amid evolving SARS-CoV-2 variants. Tenofovir did not prevent SARS-CoV-2 infection or COVID-19.

International Journal of Infectious DiseasesVol. 149
Generalitat de Catalunya (ES), Instituto de Salud Carlos III (ES), Hospital Clínic de Barcelona (ES), Barcelona Institute for Global Health (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona
Good health and well-being
Openalex Percentile: Top 77%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.